Allianz Asset Management’s NeoGenomics NEO Stock Holding History

Allianz Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-213,356	Closed	-$2.51M	–	2078
2025 Q4	$2.51M	Sell	213,356 -125,701	-37%	-$1.36M	﹤0.01%	1460
2025 Q3	$2.62M	Sell	339,057 -6,329	-2%	-$44.3K	﹤0.01%	1392
2025 Q2	$2.52M	Buy	345,386 +41,776	+14%	+$337K	﹤0.01%	1400
2025 Q1	$2.88M	Hold	303,610	–	–	﹤0.01%	1348
2024 Q4	$5M	Buy	303,610 +9,934	+3%	+$154K	0.01%	1046
2024 Q3	$4.33M	Buy	293,676 +12,875	+5%	+$201K	0.01%	1109
2024 Q2	$3.89M	Buy	280,801 +180	+0.1%	+$2.55K	0.01%	1068
2024 Q1	$4.41M	Sell	280,621 -3,773	-1%	-$58.3K	0.01%	917
2023 Q4	$4.6M	Buy	284,394 +54,669	+24%	+$895K	0.01%	953
2023 Q3	$2.83M	Sell	229,725 -4,981	-2%	-$74.1K	﹤0.01%	1267
2023 Q2	$3.77M	Buy	234,706 +17,994	+8%	+$297K	0.01%	979
2023 Q1	$3.77M	Buy	+216,712	New	+$3.09M	0.01%	1085
2022 Q2	–	Sell	-5,870	Closed	-$71K	–	2357
2022 Q1	$71K	Sell	5,870 -233,320	-98%	-$4.91M	﹤0.01%	2351
2021 Q4	$8.16M	Buy	239,190 +1,419	+0.6%	+$55.6K	0.01%	1053
2021 Q3	$11.5M	Buy	237,771 +147	+0.1%	+$6.8K	0.01%	964
2021 Q2	$10.7M	Sell	237,624 -10,044	-4%	-$445K	0.01%	827
2021 Q1	$11.9M	Buy	247,668 +230,341	+1,329%	+$12M	0.01%	778
2020 Q4	$933K	Sell	17,327 -29,141	-63%	-$1.32M	﹤0.01%	1500
2020 Q3	$1.71M	Sell	46,468 -6,350	-12%	-$236K	﹤0.01%	1303
2020 Q2	$1.64M	Sell	52,818 -67,238	-56%	-$1.86M	﹤0.01%	1684
2020 Q1	$3.31M	Sell	120,056 -65,873	-35%	-$1.97M	﹤0.01%	1339
2019 Q4	$5.44M	Sell	185,929 -6,868	-4%	-$164K	0.01%	1448
2019 Q3	$3.69M	Sell	192,797 -311,611	-62%	-$7.31M	﹤0.01%	1589
2019 Q2	$11.1M	Sell	504,408 -79,972	-14%	-$1.75M	0.01%	1146
2019 Q1	$12M	Sell	584,380 -24,207	-4%	-$421K	0.01%	1048
2018 Q4	$7.67M	Buy	608,587 +18,165	+3%	+$271K	0.01%	1242
2018 Q3	$9.06M	Buy	590,422 +50,237	+9%	+$694K	0.01%	1308
2018 Q2	$7.08M	Sell	540,185 -3,550	-0.7%	-$39.1K	0.01%	1388
2018 Q1	$4.44M	Sell	543,735 -12,618	-2%	-$102K	﹤0.01%	1580
2017 Q4	$4.93M	Sell	556,353 -123,589	-18%	-$1.14M	﹤0.01%	1624
2017 Q3	$7.57M	Sell	679,942 -27,966	-4%	-$272K	0.01%	1428
2017 Q2	$6.34M	Sell	707,908 -46,990	-6%	-$373K	0.01%	1495
2017 Q1	$5.96M	Sell	754,898 -45,690	-6%	-$372K	0.01%	1556
2016 Q4	$6.86M	Sell	800,588 -249,422	-24%	-$2.14M	0.01%	1518
2016 Q3	$8.63M	Buy	1,050,010 +248,349	+31%	+$2.08M	0.01%	1386
2016 Q2	$6.45M	Sell	801,661 -37,819	-5%	-$303K	0.01%	1397
2016 Q1	$5.66M	Sell	839,480 -43,915	-5%	-$289K	0.01%	1396
2015 Q4	$6.95M	Sell	883,395 -27,215	-3%	-$199K	0.01%	1210
2015 Q3	$5.22M	Buy	910,610 +83,422	+10%	+$516K	0.01%	1267
2015 Q2	$4.47M	Buy	827,188 +1,671	+0.2%	+$8.62K	﹤0.01%	1415
2015 Q1	$3.85M	Sell	825,517 -42,523	-5%	-$185K	﹤0.01%	1323
2014 Q4	$3.62M	Buy	868,040 +47,459	+6%	+$218K	﹤0.01%	1330
2014 Q3	$4.28M	Buy	+820,581	New	+$4.22M	0.01%	1139
2013 Q3	–	Sell	-280,500	Closed	-$1.12M	–	1819
2013 Q2	$1.12M	Buy	+280,500	New	+$1.07M	﹤0.01%	1329

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Allianz Asset Management's NEO Position: Q1 2026 in Review

Allianz Asset Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 213,356 shares — an estimated $2.51M sold.

Allianz Asset Management first reported a position in NEO in Q2 2013 and held it in 44 quarters. The position peaked at $12M in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Allianz Asset Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Allianz Asset Management sold 213,356 NeoGenomics shares in Q1 2026, an estimated $2.51M.
Allianz Asset Management first reported a position in NeoGenomics in Q2 2013 and held it in 44 quarters.
Allianz Asset Management's NeoGenomics position peaked at $12M in Q1 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.